S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin.

MLA

Sanz, E. J., et al. “S-Mephenytoin Hydroxylation Phenotypes in a Swedish Population Determined after Coadministration with Debrisoquin.” Clinical Pharmacology and Therapeutics, vol. 45, no. 5, May 1989, pp. 495–99. EBSCOhost, https://doi.org/10.1038/clpt.1989.63.

APA

Sanz, E. J., Villén, T., Alm, C., & Bertilsson, L. (1989). S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin. Clinical Pharmacology and Therapeutics, 45(5), 495–499. https://doi.org/10.1038/clpt.1989.63

Chicago

Sanz, E J, T Villén, C Alm, and L Bertilsson. 1989. “S-Mephenytoin Hydroxylation Phenotypes in a Swedish Population Determined after Coadministration with Debrisoquin.” Clinical Pharmacology and Therapeutics 45 (5): 495–99. doi:10.1038/clpt.1989.63.